Lv4
560 积分 2022-12-21 加入
Phase I safety and pharmacokinetics study of rovalpituzumab tesirine in Japanese patients with advanced, recurrent small cell lung cancer
22天前
已完结
Efficacy and safety of ongericimab in Chinese patients with heterozygous familial hypercholesterolemia: a randomized, double-blind, placebo-controlled phase 3 trial
1个月前
已完结
Valemetostat for patients with relapsed or refractory peripheral T-cell lymphoma (VALENTINE-PTCL01): a multicentre, open-label, single-arm, phase 2 study
3个月前
已完结
Advances in PSMA-targeted therapy for prostate cancer
3个月前
已完结
177Lu-Dotatate plus long-acting octreotide versus high‑dose long-acting octreotide in patients with midgut neuroendocrine tumours (NETTER-1): final overall survival and long-term safety results from an open-label, randomised, controlled, phase 3 trial
6个月前
已完结
Efficacy and safety of delgocitinib cream in adults with moderate to severe chronic hand eczema (DELTA 1 and DELTA 2): results from multicentre, randomised, controlled, double-blind, phase 3 trials
6个月前
已完结
Toripalimab or placebo plus chemotherapy as first-line treatment in advanced nasopharyngeal carcinoma: a multicenter randomized phase 3 trial
6个月前
已完结
Multiple myeloma
6个月前
已完结
Multiple myeloma
6个月前
已完结
Tazemetostat and doxorubicin in patient-derived preclinical models of epithelioid sarcoma (ES)
7个月前
已完结
Capivasertib in Hormone Receptor–Positive Advanced Breast Cancer
皖公网安备34019202002308
